Endogenous glutamine decrease is associated with pancreatic cancer progression

Pancreatic ductal adenocarcinoma (PDAC) is becoming the second leading cause of cancer-related death in the Western world. The mortality is very high, which emphasizes the need to identify biomarkers for early detection. As glutamine metabolism alteration is a feature of PDAC, its in vivo evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Roux, Cecilia, Riganti, Chiara, Borgogno, Sammy Ferri, Curto, Roberta, Curcio, Claudia, Catanzaro, Valeria, Digilio, Giuseppe, Padovan, Sergio, Puccinelli, Maria Paola, Isabello, Monica, Aime, Silvio, Cappello, Paola, Novelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707027/
https://www.ncbi.nlm.nih.gov/pubmed/29221133
http://dx.doi.org/10.18632/oncotarget.20545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707027/
https://www.ncbi.nlm.nih.gov/pubmed/29221133
http://dx.doi.org/10.18632/oncotarget.20545

Ejemplares similares